Our novel observation of increased HOXC6/miR-188-5p expression and its oncogenic activity in cancer cells suggests that HOXC6/miR-188-5p may serve as a diagnostic and, ultimately, a therapeutic tool for the effective clinical management of metastatic cancers. The gene discussed is HOXC6; the disease is cancer.